Tff Pharmaceuticals Inc (TFFP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 734 | 496 | 88 | 0 | 0 |
| Gross Profit | 734 | 496 | 88 | N/A | N/A |
| Operating Expenses | 22,629 | 32,293 | 31,875 | 18,694 | 11,988 |
| Operating Income | -21,895 | -31,797 | -31,787 | -18,694 | -11,988 |
| Other Income | 652 | 27 | 748 | 127 | 117 |
| Pre-tax Income | -21,243 | -31,770 | -31,039 | -18,567 | -11,870 |
| Net Income Continuous | -21,243 | -31,770 | -31,039 | -18,567 | -11,870 |
| Net Income | $-21,243 | $-31,770 | $-31,039 | $-18,567 | $-11,870 |
| EPS Basic Total Ops | -11.85 | -26.49 | -31.25 | -22.75 | -132.75 |
| EPS Basic Continuous Ops | -11.85 | -26.49 | -31.26 | -22.73 | -42.98 |
| EPS Diluted Total Ops | -11.85 | -26.49 | -31.25 | -22.75 | -132.75 |
| EPS Diluted Continuous Ops | -11.85 | -26.49 | -31.26 | -22.73 | -42.98 |
| EPS Diluted Before Non-Recurring Items | -11.85 | N/A | -31.25 | -22.75 | -132.75 |
| EBITDA(a) | $-21,392 | $-31,409 | $-31,675 | $-18,694 | $-11,988 |